Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zambon

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Journal of Alzheimer'S Disease : JAD|December 5, 2012
Accuracy of diagnostic criteria for sporadic creutzfeldt-jakob disease among rapidly progressive dementiaMatteo Tagliapietra, Gianluigi Zanusso, Michele Fiorini, et al.
Current Atherosclerosis Reports|July 18, 2025
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?Marta Biolo, Federica Galimberti, Camilla Portinari, et al.
Neuromuscular Disorders : NMD|October 30, 2020
Electrophysiological study of neuromuscular junction in congenital myasthenic syndromes, congenital myopathies, and chronic progressive external ophthalmoplegiaVitor Marques Caldas, Carlos Otto Heise, João Aris Kouyoumdjian, et al.
Journal of the American Heart Association|October 18, 2023
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring RegistriesMarcello Arca, Simone Celant, Pier Paolo Olimpieri, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 7, 2025
Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemiaKlaus G Parhofer, Carlos Aguiar, Maciej Banach, et al.
Cardiovascular Diabetology|July 31, 2024
Lessons from PROMINENT and prospects for pemafibrateJean-Charles Fruchart, Jamila Fruchart-Najib, Shizuya Yamashita, et al.
Diabetologia|August 9, 2021
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trialBenedetta Maria Bonora, Mattia Albiero, Mario Luca Morieri, et al.
Frontiers in Cardiovascular Medicine|June 22, 2026
Managing remnant cholesterol: role of fenofibrate-statin therapy in reducing triglyceride-rich lipoproteinsVikrama Raja, Carlos Aguiar, Nasreen Alsayed, et al.
International Journal of Molecular Sciences|July 28, 2022
HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon XanthomaMaria Pia Adorni, Marta Biolo, Francesca Zimetti, et al.
Atherosclerosis Plus|January 16, 2023
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profileMaria Giovanna Lupo, Diletta Arcidiacono, Alice Zaramella, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Journal of Alzheimer'S Disease : JAD|December 5, 2012
Accuracy of diagnostic criteria for sporadic creutzfeldt-jakob disease among rapidly progressive dementiaMatteo Tagliapietra, Gianluigi Zanusso, Michele Fiorini, et al.
Current Atherosclerosis Reports|July 18, 2025
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?Marta Biolo, Federica Galimberti, Camilla Portinari, et al.
Neuromuscular Disorders : NMD|October 30, 2020
Electrophysiological study of neuromuscular junction in congenital myasthenic syndromes, congenital myopathies, and chronic progressive external ophthalmoplegiaVitor Marques Caldas, Carlos Otto Heise, João Aris Kouyoumdjian, et al.
Journal of the American Heart Association|October 18, 2023
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring RegistriesMarcello Arca, Simone Celant, Pier Paolo Olimpieri, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 7, 2025
Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemiaKlaus G Parhofer, Carlos Aguiar, Maciej Banach, et al.
Cardiovascular Diabetology|July 31, 2024
Lessons from PROMINENT and prospects for pemafibrateJean-Charles Fruchart, Jamila Fruchart-Najib, Shizuya Yamashita, et al.
Diabetologia|August 9, 2021
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trialBenedetta Maria Bonora, Mattia Albiero, Mario Luca Morieri, et al.
Frontiers in Cardiovascular Medicine|June 22, 2026
Managing remnant cholesterol: role of fenofibrate-statin therapy in reducing triglyceride-rich lipoproteinsVikrama Raja, Carlos Aguiar, Nasreen Alsayed, et al.
International Journal of Molecular Sciences|July 28, 2022
HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon XanthomaMaria Pia Adorni, Marta Biolo, Francesca Zimetti, et al.
Atherosclerosis Plus|January 16, 2023
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profileMaria Giovanna Lupo, Diletta Arcidiacono, Alice Zaramella, et al.
Pageof 10